Testing Designated Clause Samples

Testing Designated. Positions (1) In addition to the general WSAP provisions, Seller shall determine if it has employees in TDPs as defined below and performing WSAP covered work. If Seller has no TDPs (potentially the case for uncleared construction subcontractors employees not possessing a Facility Clearance) the WSAP shall so state. If Seller has employees in TDPs performing WSAP covered work, then prior to beginning work under this Agreement, Seller shall provide the Subcontract Administrator with a list of all TDP employees, and Seller’s WSAP must comply with the provisions of 10 CFR Part 707 regarding TDPs. Thereafter, Seller shall notify the STR of any additions or deletions of employees in TDPs within 48 hours. (2) TDPs are defined as those positions involving certain high risk work listed in Part 707, access to classified information, construction, and crane operators, and any positions filled by employees holding an L- or Q-clearance. (3) Seller’s employees in TDPs who perform on-site will be subjected to the following drug testing by Company: (i) Random drug testing at the rates specified in 10 CFR 707.7, (ii) Drug testing as a result of an occurrence (see 10 CFR 707.9), and (iii) Drug testing for reasonable suspicion of illegal drug use (see 10 CFR 707.10). (4) Seller’s employees performing on-site work shall be placed in Company’s pool of employees for random drug testing, and these employees will be subject to testing by Company’s Occupational Health Services (OHS). Seller’s employee will be notified by Company’s representative when ▇▇▇▇▇▇’s employee is selected for random drug testing. Company’s representative will notify Company’s OHS when ▇▇▇▇▇▇’s employee has been notified of his/her duty to report to Company’s OHS. Upon notification by Company’s representative, ▇▇▇▇▇▇’s employee will have one and one-half hours to report to Company’s OHS.